CP-464709

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCP-464709

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGrowth hormone releasing factor agonists

TargetsGrowth hormone releasing factor

Therapy Area/IndicationsOsteoporosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsOsteoporosis

ATC CodeN/A